SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-059538
Filing Date
2024-05-14
Accepted
2024-05-14 16:09:38
Documents
13
Period of Report
2024-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crgx-20240514.htm   iXBRL 8-K 40751
2 EX-99.1 crgx-ex99_1.htm EX-99.1 92146
3 GRAPHIC img19376069_0.jpg GRAPHIC 4001
  Complete submission text file 0000950170-24-059538.txt   269449

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crgx-20240514.xsd EX-101.SCH 26947
16 EXTRACTED XBRL INSTANCE DOCUMENT crgx-20240514_htm.xml XML 5166
Mailing Address 1900 ALAMEDA DE LAS PULGAS SUITE 350 SAN MATEO CA 94403
Business Address 1900 ALAMEDA DE LAS PULGAS SUITE 350 SAN MATEO CA 94403 650-379-6143
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

IRS No.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 24944377
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)